From Barchart: 2024-11-15 07:47:00

Goldman Sachs analysts started coverage on Doximity (NYSE:DOCS) with a Neutral rating and a price target of $58, citing the company’s strong market position and growth potential. They projected a compound annual revenue growth rate of 9-10% from fiscal 2025 to fiscal 2028, outpacing the market’s 6-7% annual performance.

Doximity, a leader in an attractive end-market, is expected to expand its core customer base and achieve fiscal 2025 guidance. Goldman Sachs also highlighted a projected 180 basis point increase in EBITDA margins from fiscal 2025 to fiscal 2028, driven by operational efficiencies. However, the Neutral rating reflects limited upside potential at current valuation levels.



Read more at Barchart:: Goldman Sachs Initiates Neutral Coverage on Doximi…